About MSD Animal Health

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. MSD Animal Health, known as Merck Animal Health in the United States and Canada, is the global animal health business unit of MSD. We offer one of the industry’s most innovative portfolios, not only of products, but also of services and technologies, to prevent, treat and control diseases across all major farm and companion animal species. We maintain commercial offices in more than 50 countries and business operations in more than 150 markets, and run a global network of manufacturing and R&D facilities.

Our mission – The Science of Healthier Animals – guides all of our work. Healthier animals mean a sustainable food supply, protection for humans against diseases passed from animals, and longer, healthier lives for pets. We understand that our customers face challenges that are wider, more complex and evolving faster than ever. We are committed to providing the products, technologies, services and insights to help our customers meet their needs.

Global trade, migration and climate change can increase the spread of highly infectious diseases that devastate animal populations, threaten human health, and disrupt the food supply. We know that only a fast and flexible approach will control the spread of disease and protect our communities and food supplies.

Rising incomes in many countries translate into more people with the desire, time and money to keep pets in the home. As pet ownership increases, so does the need for state-of-the-art products and services to help pets’ live longer and healthier lives. To help pet owners control parasites, we introduced BRAVECTO® the first chew for dogs and spot-on for dogs and cats that is systemically effective against fleas and ticks for up to 12 weeks. This persistent efficacy improves convenience and compliance in parasite control. To help manage diabetes, CANINSULIN® is approved for use in dogs and cats and can be administered using VETPEN®, the first veterinary insulin pen, featuring consistently accurate dosing, greater convenience and more comfortable injections. Through support and added-value services, such as our Pet Diabetes Tracker app, pet owners can record the progress of their diabetic pet and report this to their veterinarian. Vaccination continues to be an important way to protect pets around the world. Our broad range of Nobivac® vaccines provides outstanding protection for dogs, cats, and rabbits to keep them living long, healthy lives.

Our robust R&D pipeline spans key therapeutic areas, providing a solid platform for further pharmaceutical and vaccine advances in veterinary medicine. Still, our customers expect more from us than just medicines. As a multi-species global company, we respond readily to the demands of our dynamic industry, working in close collaboration with our customers to deliver the information, technologies and veterinary services to meet their needs around the world. 

For more information, visit or connect with us on LinkedIn.